human papilloma virus HPV PCR - Taizhou Cowingene Biotech Co., Ltd.|HPV Detection, Genotyping

The Cowingene HPV 28 Genotyping Detection Kit represents a significant advancement in molecular diagnostics for human papillomavirus (HPV) detection. Designed for clinical and research applications, this kit utilizes human papilloma virus HPV PCR technology to identify 28 high-risk HPV genotypes with exceptional accuracy. Developed by Taizhou Cowingene Biotech Co., Ltd., the kit is engineered to meet the rigorous demands of modern diagnostic laboratories.

Read More About human papilloma virus HPV PCR

Product Overview

The Cowingene HPV 28 Genotyping Detection Kit is a molecular diagnostic tool that leverages polymerase chain reaction (PCR) technology to detect and genotype 28 high-risk HPV strains. This kit is particularly valuable for early detection of cervical cancer and other HPV-related diseases. The product is validated for use with cervical swab, urine, and self-collected vaginal specimens, making it a versatile solution for diverse clinical settings.

Read More About HPV detection by PCR

Key Features and Advantages

• Comprehensive Genotype Coverage: Detects 28 high-risk HPV genotypes, including 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83, and others.
• High Sensitivity and Specificity: Utilizes advanced PCR techniques to ensure reliable results, even with low viral loads.
• Flexible Sample Types: Compatible with cervical swabs, urine, and self-collected vaginal samples, enhancing patient compliance and convenience.
• Streamlined Workflow: Designed for ease of use in laboratory settings, with minimal hands-on time and rapid processing.
• Compliance with Standards: Adheres to international diagnostic standards, ensuring reproducibility and regulatory compliance.

Read More About human papillomavirus PCR

Technical Specifications

Parameter	Details
Detection Method	Human Papilloma Virus HPV PCR
Number of Genotypes Detected	28 High-Risk HPV Genotypes
Validated Specimens	Cervical Swab, Urine, Self-Collected Vaginal
Sample Volume	1-2 mL (depending on specimen type)
Assay Time	Approximately 2.5 hours
Storage Conditions	-20°C for reagents; 2-8°C for completed assays
Kit Components	PCR Master Mix, Primers, Controls, and Reagents

Applications in Clinical and Research Settings

The Cowingene HPV 28 Genotyping Detection Kit is widely applicable in both clinical diagnostics and research. In clinical settings, it aids in the early detection of cervical cancer by identifying high-risk HPV infections. The kit's ability to genotype multiple strains simultaneously provides critical data for patient management and treatment planning. In research, it supports epidemiological studies, vaccine development, and the evaluation of HPV transmission dynamics.

Company Background: Taizhou Cowingene Biotech Co., Ltd.

Founded in 2015, Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and infectious disease testing. The company's mission is to develop innovative, affordable, and reliable diagnostic solutions that address global health challenges. With a focus on research and development, Cowingene has established itself as a trusted name in the field of PCR-based diagnostics.

As a member of the National Institute of Standards and Technology (NIST) collaborative network, Cowingene adheres to rigorous quality control standards. NIST's role in establishing measurement standards ensures that the company's products meet the highest levels of accuracy and reliability. This partnership underscores Cowingene's commitment to excellence in diagnostic technology.

Why Choose the Cowingene HPV 28 Genotyping Detection Kit?

The Cowingene HPV 28 Genotyping Detection Kit stands out in the market due to its combination of advanced technology, user-friendly design, and comprehensive coverage of high-risk HPV genotypes. Unlike traditional methods that may require multiple tests, this kit provides a single, efficient solution for detecting a wide range of HPV strains. The kit's compatibility with diverse specimen types also enhances its utility in both clinical and research environments.

Ensuring Accuracy and Reliability

The accuracy of the Cowingene HPV 28 Genotyping Detection Kit is validated through extensive testing and adherence to international standards. The kit's performance is regularly evaluated against NIST reference materials to ensure consistency and reliability. This validation process is critical for diagnostic tools, as it guarantees that results are both precise and reproducible across different laboratories and settings.

Future Directions and Innovations

As the field of molecular diagnostics continues to evolve, Cowingene remains at the forefront of innovation. The company is actively researching next-generation sequencing (NGS) technologies to further enhance the capabilities of its HPV detection products. By integrating advanced data analysis tools, Cowingene aims to provide even more comprehensive insights into HPV infections, ultimately improving patient outcomes and public health strategies.

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit is a testament to the power of molecular diagnostics in combating HPV-related diseases. With its advanced PCR technology, comprehensive genotype coverage, and user-friendly design, this kit offers a reliable solution for both clinical and research applications. As Taizhou Cowingene Biotech Co., Ltd. continues to innovate, it remains committed to advancing global health through cutting-edge diagnostic solutions.

References

National Institute of Standards and Technology (NIST). (n.d.). Standards for Molecular Diagnostics. Retrieved from https://www.nist.gov/

Taizhou Cowingene Biotech Co., Ltd.. (n.d.). Product Specifications and Validation Data. Retrieved from https://www.cowingene.com/